L LGND

Ligand Pharmaceuticals Inc - Class B

$204.24

+0.83% (+$1.69)

Volume 176,080

52W High $212.49

52W Low $93.58

Market Cap $3.77B

← Back to Calendar Compare with Others →

What to Watch This Quarter

Based on historical data

Consensus EPS

$1.49

Whisper EPS

$1.59

6.9% above consensus

Last Quarter

--

Current Streak

1 Beat

Avg Surprise (4Q)

-11.56%

Next Earnings Report

Report Date Mar 4, 2026

Whisper Spread +6.90%

Consensus Estimate

$1.49

Official analyst average

Whisper Number

$1.59

What traders expect

Bullish Sentiment: The whisper number is 6.9% above consensus, suggesting traders expect a strong beat. The stock may be priced for upside surprise.

Price Chart

EPS History: Consensus vs Actual

Last 11 quarters

Price Movement Around Earnings

Q4 2025 Feb 26, 2026

1-Day: +1.09%

5-Day: +4.11%

Q3 2025 Nov 6, 2025

1-Day: -2.76%

5-Day: +0.23%

Q2 2025 Aug 8, 2025

5-Day: +3.96%

Q1 2025 May 5, 2025

1-Day: -2.85%

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q4 2025	Feb 26, 2026	$1.50	$1.61	--	--	--
Q3 2025	Nov 6, 2025	$1.93	$2.04	$3.09	+60.10%	Beat
Q2 2025	Aug 8, 2025	$1.43	$1.64	$0.24	-83.22%	Missed
Q1 2025	May 5, 2025	$0.78	$0.90	$1.33	+70.51%	Beat
Q4 2024	Feb 25, 2025	$1.19	$1.37	$1.27	+6.71%	Missed
Q3 2024	Nov 7, 2024	$1.35	$1.55	$1.84	+36.30%	Beat
Q2 2024	Aug 6, 2024	$1.06	$1.22	$1.40	+32.08%	Beat
Q1 2024	May 7, 2024	$0.78	$0.90	$1.20	+53.85%	Beat
Q4 2023	Feb 27, 2024	$0.66	$0.76	$1.38	--	Beat
Q3 2023	Nov 8, 2023	$0.61	$0.70	$1.02	+67.21%	Beat
Q2 2023	Aug 8, 2023	$0.64	$0.74	$1.42	--	Beat
Q1 2023	May 4, 2023	$0.89	$1.02	$2.28	--	Beat